INBX
Inhibrx Biosciences, Inc.
Recent 8-K filings for INBX
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 11, 2026 20:02 UTC other_material item 7.01item 8.01item 9.01
Inhibrx: INBRX-106 + pembro achieves 44% ORR vs 21.4% in HNSCC Phase 2
source · INBX on sec.gov